PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells. Chivot J, Ferrand N, Fert A, Van Dreden P, Morichon R, Sabbah M. Int J Mol Sci. 2022 Dec 18;23(24):16171. doi: 10.3390/ijms232416171. Free Full Text